statistiche ricercatore

Nazione	#
US - Stati Uniti d'America	1.019
SG - Singapore	196
CN - Cina	159
IT - Italia	133
GB - Regno Unito	74
BR - Brasile	71
VN - Vietnam	56
HK - Hong Kong	53
DE - Germania	46
SE - Svezia	39
FR - Francia	33
KR - Corea	21
RU - Federazione Russa	21
IN - India	17
FI - Finlandia	11
ID - Indonesia	11
MX - Messico	11
CA - Canada	9
IQ - Iraq	9
LT - Lituania	9
BD - Bangladesh	8
TR - Turchia	8
NL - Olanda	7
UA - Ucraina	7
ZA - Sudafrica	7
AR - Argentina	6
IR - Iran	6
AT - Austria	5
BG - Bulgaria	5
ES - Italia	4
JO - Giordania	4
MA - Marocco	4
MY - Malesia	4
CL - Cile	3
DZ - Algeria	3
EG - Egitto	3
PE - Perù	3
PH - Filippine	3
PK - Pakistan	3
PL - Polonia	3
SA - Arabia Saudita	3
VE - Venezuela	3
AU - Australia	2
AZ - Azerbaigian	2
BE - Belgio	2
EC - Ecuador	2
GR - Grecia	2
JP - Giappone	2
KE - Kenya	2
PY - Paraguay	2
RO - Romania	2
UZ - Uzbekistan	2
AO - Angola	1
BY - Bielorussia	1
CG - Congo	1
CM - Camerun	1
CO - Colombia	1
DO - Repubblica Dominicana	1
ET - Etiopia	1
GA - Gabon	1
HN - Honduras	1
HR - Croazia	1
IL - Israele	1
JM - Giamaica	1
KG - Kirghizistan	1
KH - Cambogia	1
LA - Repubblica Popolare Democratica del Laos	1
OM - Oman	1
PA - Panama	1
RS - Serbia	1
SN - Senegal	1
TN - Tunisia	1
UY - Uruguay	1
Totale	2.141

Nome	#
Clinical and molecular epidemiology of erythropoietic protoporphyria in Italy	400
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity	340
Prevalence and predictors of liver fibrosis evaluated by vibration controlled transient elastography in type 1 Gaucher disease	299
Current challenges in the management of patients with sickle cell disease - A report of the Italian experience	276
Liver steatosis is highly prevalent and is associated with metabolic risk factors and liver fibrosis in adult patients with type 1 Gaucher disease	242
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	177
Key Terms and Definitions in Acute Porphyrias: Results of an International Delphi Consensus Led by the European Porphyria Network	163
Efficacy and safety of givosiran for acute hepatic porphyria: Final results of the randomized phase III ENVISION trial	145
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation	122
Totale	2.164

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	61	0	0	0	0	0	0	0	0	0	28	23	10
2021/2022	157	10	5	29	2	2	13	7	2	19	20	37	11
2022/2023	149	17	21	8	15	20	18	4	10	9	0	14	13
2023/2024	130	3	7	12	7	18	10	18	11	8	8	12	16
2024/2025	446	10	8	7	23	66	51	45	40	53	35	48	60
2025/2026	819	71	51	83	109	129	67	128	34	81	66	0	0
Totale													2.164